T-Cell Progenitors As A New Immunotherapy to Bypass Hurdles of Allogeneic Hematopoietic Stem Cell Transplantation

Overview of attention for article published in Frontiers in immunology, July 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 14 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 34,835 followers.

RT @FrontImmunol: New Research: T-Cell Progenitors As A New Immunotherapy to Bypass Hurdles of Allogeneic Hematopoietic Stem Cell Transplan…

08 Jul 2022

Reply Repost Favourite

RT @FrontImmunol: New Research: T-Cell Progenitors As A New Immunotherapy to Bypass Hurdles of Allogeneic Hematopoietic Stem Cell Transplan…

07 Jul 2022

Reply Repost Favourite

RT @FrontImmunol: New Research: T-Cell Progenitors As A New Immunotherapy to Bypass Hurdles of Allogeneic Hematopoietic Stem Cell Transplan…

07 Jul 2022

Reply Repost Favourite

New Research: T-Cell Progenitors As A New Immunotherapy to Bypass Hurdles of Allogeneic Hematopoietic Stem Cell Transplantation: Allogeneic hematopoietic stem cell transplantation (HSCT) is the treatment of preference for numerous malignant… https://t.co/F

07 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.